Structural mechanisms for VMAT2 inhibition by tetrabenazine

被引：0
作者：
Dalton, Michael P. [1 ]
Cheng, Mary H. [2 ,3 ]
Bahar, Ivet [2 ,3 ]
Coleman, Jonathan [1 ]
机构：
[1] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA USA
[2] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY USA
[3] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY USA
来源：
BIOPHYSICAL JOURNAL | 2024年 / 123卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
625-Pos
引用
收藏
页码：116A / 116A
页数：1
相关论文
共 50 条
  • [31] Lobeline analogs as potent and selective VMAT2 antagonists
    Crooks, Peter A.
    Zheng, Guangrong
    Deaciuc, Agripina G.
    Dwoskin, Linda P.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S29 - S30
  • [32] Association of VMAT2 gene polymorphisms with alcohol dependence
    Christoph Fehr
    Daniel Sommerlad
    Thomas Sander
    Ion Anghelescu
    Norbert Dahmen
    Armin Szegedi
    Christiana Mueller
    Peter Zill
    Michael Soyka
    Ulrich W. Preuss
    Journal of Neural Transmission, 2013, 120 : 1161 - 1169
  • [33] Structural snapshots of human VMAT2 reveal insights into substrate recognition and proton coupling mechanism
    Wu, Di
    Yu, Zhuoya
    Chen, Qihao
    Zhao, Jun
    Huang, Bo
    Wang, Yuhang
    Su, Jiawei
    Li, Na
    Jiang, Daohua
    Zhao, Yan
    CELL RESEARCH, 2024, 34 (08) : 586 - 589
  • [34] New generation VMAT2 inhibitors induced parkinsonism
    Vasireddy, Rani Priyanka
    Sokola, Brent
    Guduru, Zain
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
  • [35] Association of VMAT2 gene polymorphisms with alcohol dependence
    Fehr, Christoph
    Sommerlad, Daniel
    Sander, Thomas
    Anghelescu, Ion
    Dahmen, Norbert
    Szegedi, Armin
    Mueller, Christiana
    Zill, Peter
    Soyka, Michael
    Preuss, Ulrich W.
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (08) : 1161 - 1169
  • [36] Real-World Experience With VMAT2 Inhibitors
    Niemann, Nicki
    Jankovic, Joseph
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (02) : 37 - 41
  • [37] VMAT2 inhibitors for the treatment of hyperkinetic movement disorders
    Koch, Jessa
    Shi, Wei-Xing
    Dashtipour, Khashayar
    PHARMACOLOGY & THERAPEUTICS, 2020, 212
  • [38] Identification of a novel interaction between α-synuclein and VMAT2
    Dean, E. Danielle
    Shepherd, Kennie Raviie
    Li, Yingjie
    Torres, Gonzalo E.
    Miller, Gary W.
    FASEB JOURNAL, 2008, 22
  • [39] Inhibition of VMAT2 differentially modulates malonate-induced toxicity to dopamine neurons in vivo.
    Moy, LY
    Sonsalla, PK
    FASEB JOURNAL, 2000, 14 (08) : A1475 - A1475
  • [40] JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death
    Choi, Won-Seok
    Kim, Hyung-Wook
    Xia, Zhengui
    TOXICOLOGY, 2015, 328 : 75 - 81
12345